Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EDSA stock hub

Edesa Biotech, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EDSAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

144.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

EDSA

In the news

Latest news · EDSA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-96.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-64.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EDSA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001540159
Company name	Edesa Biotech, Inc.
Country	Canada
Country code	US
Cusip	27966L108
Employees	17
Employees Change	1%
Employees Change Percent	6.25
Enterprise value	$132.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA27966L3065
Last refreshed	2026-05-10
Market cap	$144.8M
Market cap category	Micro-Cap
Price	$16.3
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	EDSA
Website	https://www.edesabiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.4%
FCF yield	-5.45%
P/B ratio	29.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-7.8M
Net Income Growth Years	0%
Profit Per Employee	$-459,761
ROA	-55.33
Roa5y	-77.39
ROCE	-59.87
ROE	-96.38
Roe5y	-123
ROIC	-64.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	615.88%
Cagr3y	29.99%
Cagr5y	-18.26%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$14.7M
Cash	$12.1M
Current Assets	$12.7M
Current Liabilities	$756,163
Equity	$14M
Liabilities	$756,163
Long Term Assets	$2M
Long Term Liabilities	$0
Net Cash	$12.1M
Net Cash By Market Cap	$8.32
Net Cash Growth	670.82%
Net Debt Equity	$-0.86
Tangible Book Value	$2.7M
Tangible Book Value Per Share	$0.32
WACC	11.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	16.82
Net Working Capital	$-90,424
Quick ratio	16.51
Working Capital	$12M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-110.15%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	614.91%
200-day SMA	3.41
3Y total return	119.68%
50-day SMA	7.91
50-day SMA vs 200-day SMA	50over200
5Y total return	-63.5%
All Time High	133.7
All Time High Change	-87.81%
All Time High Date	2020-07-30
All Time Low	0.72
All Time Low Change	2,163.89%
All Time Low Date	2026-02-20
ATR	1.98
Beta	1.28
Beta1y	-2.67
Beta2y	-0.57
Ch YTD	1,047.9
High	17.81
High52	20.32
High52 Date	2026-05-01
High52ch	-19.78%
Low	16.3
Low52	0.72
Low52 Date	2026-02-20
Low52ch	2,163.89%
Ma50ch	105.96%
Premarket Change Percent	-0.29
Premarket Price	$17.38
Premarket Volume	25,730
Price vs 200-day SMA	377.59%
RSI	68.06
RSI Monthly	72.35
RSI Weekly	81.17
Sharpe ratio	1.76x
Sortino ratio	5.53
Total Return	-110.15%
Tr YTD	1,047.9
Tr1m	169.42%
Tr1w	-7.33%
Tr3m	1,355.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.26
Operating Income	$-8.4M
Price target	$5
Price Target Change	$-69.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,102,628%
Float Percent	46.17%
Shares Insiders	7.96%
Shares Institutions	4.56%
Shares Out	8,885,719
Shares Qo Q	13.01%
Shares Yo Y	110.15%
Short Float	6.52%
Short Ratio	0.28
Short Shares	3.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.9M
Average Volume	1,074,101.85x
Bv Per Share	0.56
Ch1m	169.4
Ch1w	-7.33
Ch1y	614.9
Ch3m	1,355.4
Ch3y	119.7
Ch5y	-63.5
Ch6m	853.2
Change	-6.48%
Change From Open	-5.73
Close	17.43
Days Gap	-0.8
Depreciation Amortization	101,624
Dollar Volume	4,754,302.5
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-8.4M
EBITDA	$-8.3M
EPS	$-1.14
F Score	1
FCF	$-7.9M
FCF EV Yield	-5.94x
FCF Per Share	$-0.89
Financing CF	18,314,772
Fiscal Year End	September
Founded	2,015
Income Tax	$800
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Last Split Date	2023-10-11
Last Split Type	Reverse
Last10k Filing Date	2025-12-12
Ma150	3.76
Ma150ch	333.28%
Ma20	11.03
Ma20ch	47.85%
Net CF	10,488,246
Next Earnings Date	2026-05-22
Open	17.29
Optionable	No
Position In Range	0
Post Close	16.3
Postmarket Change Percent	0.61
Postmarket Price	$16.4
Pre Close	17.43
Price Date	2026-05-08
Ptbv Ratio	53.56
Relative Volume	0.27x
Share Based Comp	1,048,321
Tr6m	853.22%
Volume	291,675

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EDSA pay a dividend?

Capital-return profile for this ticker.

Performance

EDSA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EDSA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.6%

Float: +46.2% of shares outstanding

Insider ownership

+8.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EDSA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.1

Neutral momentum band

Price vs 200-day MA

+377.6%

50/200-day relationship not available

Beta (5Y)

1.28

More volatile than the market

Sharpe ratio

1.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EDSA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EDSA stock rating?

Edesa Biotech, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EDSA analysis?

The full report lives at /stocks/EDSA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EDSA?

The latest report frames EDSA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EDSA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.